ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Lung transplantation"

  • 2022 American Transplant Congress

    Simultaneous Lung and Kidney Transplant in a Young Patient with COVID-19

    M. Bitar1, J. G. Youssef2, S. Yau2, A. Goodarzi2, G. Youssef3

    1Houston Methodist Academic Pulmonary Medicine, Houston Methodist Hospital, Houston, TX, 2Houston Methodist Pulmonary Transplant Center, Houston Methodist Hospital, Houston, TX, 3Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

    *Purpose: Lung transplant is the last resort for COVID-19 refractory ARDS. Dual organ transplant is seen as a relative contraindication at many institutions. We describe…
  • 2022 American Transplant Congress

    CD31+ Extracellular Vesicles in Ex Vivo Lung Perfusion Are Associated with Unsuitability for Transplant

    G. C. Madu1, S. Moshkelgosha2, A. Chruscinski3, A. Sage2, M. Cypel2, S. Keshavjee2, S. Juvet2

    1Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Multi-Organ Transplantation, University Health Network, Toronto, ON, Canada

    *Purpose: Primary graft dysfunction (PGD) is an important cause of morbidity and mortality following lung transplantation and results in part from injuries sustained in the…
  • 2022 American Transplant Congress

    Longitudinal Analysis of the Lung Microbiome and Immune Status in Lung Transplant Recipients

    Y. Zhao, P. Zhang, Y. Su, Y. Zhu, L. Shen

    Shanghai Pulmonary Hospital, Shanghai, China

    *Purpose: The dynamic remodeling of lung flora structure and the association between microbial community dynamics and immune status after lung transplantation (LTx) remain unclear.*Methods: Fourteen…
  • 2022 American Transplant Congress

    Lung Transplantation Outcomes in Recipients Living with HIV in the United States

    J. M. Czeresnia1, S. Madan2, M. M. Abbasi3, V. Hemmige1

    1Department of Medicine - Division of Infectious Diseases, Montefiore Medical Center, Bronx, NY, 2Department of Medicine - Division of Cardiology, Montefiore Medical Center, Bronx, NY, 3Department of Surgery - Division of Cardiovascular and Thoracic Surgery, Montefiore Medical Center, Bronx, NY

    *Purpose: To compare outcomes of lung transplantation in HIV-positive and HIV-negative recipients in the United States.*Methods: A national transplant database (UNOS/SRTR) was queried for cases…
  • 2022 American Transplant Congress

    Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection

    L. Zaffiri, R. Hallak, S. Leonard, M. Neely, A. Hulber, H. Berry, K. A. Young, J. M. Reynolds

    Duke University, Durham, NC

    *Purpose: Antibody-mediated rejection (AMR) is cause of significant morbidity and mortality in lung transplant recipients (LTRs). An optimal therapeutic regimen is still lacking. Recent evidence…
  • 2022 American Transplant Congress

    The Impact of Tacrolimus Trough Variability on Acute Rejection Following Lung Transplantation

    K. Evans1, K. Beermann1, H. Lee2, M. Harris1, C. W. Frankel3, H. Berry1, H. Ali3

    1Pharmacy, Duke Health, Durham, NC, 2Biostatistics and Bioinformatics, Duke University, Durham, NC, 3Pulmonary, Allergy, and Critical Care, Duke Health, Durham, NC

    *Purpose: This study aimed to evaluate the association of tacrolimus coefficient of variation (CV) with biopsy-proven acute cellular rejection in the first year following lung…
  • 2022 American Transplant Congress

    More Than Just Drain Pipes, Pulmonary Lymphatics Play a Pivotal Role in the Development of Bronchiolitis Obliterans Syndrome

    L. Wang1, R. Han2, H. Outtz Reed3, W. W. Hancock2

    1Childrens Hospital of Phila, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Weill Cornell, New York, NY

    *Purpose: Chronic allograft dysfunction (CLAD) remains a major determinant of the generally poor long-term outcome of lung transplantation compared to that of other solid organ…
  • 2022 American Transplant Congress

    Risk Factors for Extubation Failure Post- Lung Transplantation

    A. J. Trindade1, W. D. Gannon1, A. G. Dragnich1, G. Dahlberg1, C. T. Demarest2, E. S. Lambright2, K. A. McPherson1, S. G. Norfolk1, C. M. Shaver1, I. M. Robbins1, M. Bacchetta2

    1Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Extubation delays following lung transplantation can result in delirium, deconditioning, infections, and increased hospital length of stay. Risk stratifying patients for extubation failure may…
  • 2022 American Transplant Congress

    Incidence and Laterality of Pulmonary Emboli in Single Lung Transplant Recipients

    F. Pyarali1, J. Thomas2, A. Peiris2, R. Rampolla1

    1Department of Pulmonary and Critical Care, Cedars Sinai Medical Center, Los Angeles, CA, 2Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA

    *Purpose: Lung transplantation surgery increases the risk of pulmonary embolism (PE), with an incidence described between 6% to 27%, based on data from 15 years…
  • 2022 American Transplant Congress

    Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients

    R. Gordon1, K. Dewey1, R. Jariwala1, B. Yen1, J. Kukreja2, S. Hays2, J. Singer2, R. Florez1

    1Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA

    *Purpose: We hypothesized that crushed posaconazole delayed release (POSA DR) tablets can reach therapeutic levels in lung transplant recipients who are at risk for invasive…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 42
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences